Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy Source: Eur Respir J 2001; 18: 243-245 Year: 2001
Pulmonary toxicity during chemotherapy with etopiside and carboplatin Source: Eur Respir J 2003; 22: Suppl. 45, 64s Year: 2003
Gemcitabine induced pulmonary toxicity with late oncet Source: Eur Respir J 2006; 28: Suppl. 50, 382s Year: 2006
Effect of pulse therapy with glucocorticoid and cyclophosphamide on lung fibrosis due to paraquat poisoning in rat Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010
Antituberculosis chemotherapy toxicity reduction Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
Immunomodulating activity of inhalations of ultra-low doses of alkylating drug melphalan for severe bronchial asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
Survival and respiratory effects in NSCLC patients after treatment with inhaled carboplatin Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
The inhalation of very low doses of alkylating drug as the treatment of severe asthma: five-year results Source: Eur Respir J 2002; 20: Suppl. 38, 54s Year: 2002
Combined cytotoxic treatment (methotrexate and cyclophosphamide) in association with prednisone in sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 713s Year: 2004
Incidence and timing of hepatotoxicity due to anti-tuberculous treatment Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011
Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis? Source: Eur Respir J, 51 (1) 1701737; 10.1183/13993003.01737-2017 Year: 2018
Therapeutic effectiveness of early and late surfactant-BL administration in bleomycine induced injury of lung in rats Source: Eur Respir J 2003; 22: Suppl. 45, 532s Year: 2003
Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC Source: ERJ Open Res, 3 (1) 00128-2016; 10.1183/23120541.00128-2016 Year: 2017
Hypersensitivity pneumonitis associated with the use of temozolomide Source: Eur Respir J 2009; 33: 931-934 Year: 2009
Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients Source: Eur Respir Rev 2013; 22: 93-95 Year: 2013
Effect of Nintedanib in a rat model of lung fibrosis induced by single or double bleomycin administration Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017
Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004
LSC 2014 abstract - Deglycosylated bleomycin, while keeping bleomycin's antitumor activity, is devoid of its strong pulmonary toxicity Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells Year: 2014
Pathological evaluation of the bleomycin induced lung injury in rats Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008
Cisplatin and docetaxel induction chemotherapy results Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005